Phase II Pilot Study of Imatinib Mesylate for the Treatment of Severe Sclerotic Skin Chronic Graft Versus Host Disease (ScGVHD)

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Treatment of Chronic Graft-Versus-Host Disease in 2011

Current Opinion in Hematology
Hematology
2011English

An Investigator Initiated Phase II Clinical Trial of Tamibarotene (AM80G) for Chronic Graft-Versus-Host Disease

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2015English

CO2 Laser in Oral Graft-Versus-Host Disease: A Pilot Study

Bone Marrow Transplantation
TransplantationHematology
2003English

Principles of Non-Pharmacological Correction of Skin Toxicity and Skin Manifestations of a Chronic «Graft Versus Host» Disease

Onkopediatria
Child HealthOncologyPediatricsPerinatology
2019English

A Prospective Study of Female Genital Chronic Graft-Versus-Host Disease Symptoms, Signs, Diagnosis, and Treatment

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2018English

Diverse Activity of IL-17+ Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease

Archivum Immunologiae et Therapiae Experimentalis
MedicineAllergyImmunology
2019English

Feasibility of NIH Consensus Criteria for Chronic Graft-Versus-Host Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy